233 related articles for article (PubMed ID: 9416775)
1. Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
Kobayashi T; Araki T; Itoyama Y; Takeshita M; Ohta T; Oshima Y
Life Sci; 1997; 61(26):2529-38. PubMed ID: 9416775
[TBL] [Abstract][Full Text] [Related]
2. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
[TBL] [Abstract][Full Text] [Related]
3. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
Ushijima I; Mizuki Y; Yamada M
Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
[TBL] [Abstract][Full Text] [Related]
4. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
5. Effects of microgram doses of haloperidol on open-field behavior in mice.
Conceição IM; Frussa-Filho R
Pharmacol Biochem Behav; 1996 Apr; 53(4):833-8. PubMed ID: 8801585
[TBL] [Abstract][Full Text] [Related]
6. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase inhibitors cause motor deficits in mice.
Araki T; Mizutani H; Matsubara M; Imai Y; Mizugaki M; Itoyama Y
Eur Neuropsychopharmacol; 2001 Apr; 11(2):125-33. PubMed ID: 11313158
[TBL] [Abstract][Full Text] [Related]
8. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
9. [Emetic and catalepsy-inducing actions of buflomedil].
Koda H; Hashimoto T; Kuriyama K
Nihon Yakurigaku Zasshi; 1988 Dec; 92(6):375-9. PubMed ID: 3250915
[TBL] [Abstract][Full Text] [Related]
10. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Maj J; Rogóz Z; Skuza G
J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
[TBL] [Abstract][Full Text] [Related]
11. Influence of dopamine agonists and an opiate antagonist on agaricus-induced catalepsy, as tested by a new method.
Sukul NC; Klemm WR
Arch Int Pharmacodyn Ther; 1988; 295():40-51. PubMed ID: 2907723
[TBL] [Abstract][Full Text] [Related]
12. Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
Taniguchi R; Nakagawasai O; Tan-no K; Yamadera F; Nemoto W; Sato S; Yaoita F; Tadano T
Biosci Biotechnol Biochem; 2013; 77(2):266-70. PubMed ID: 23391905
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro.
Ogawa N; Tanaka K; Asanuma M; Kawai M; Masumizu T; Kohno M; Mori A
Brain Res; 1994 Sep; 657(1-2):207-13. PubMed ID: 7820619
[TBL] [Abstract][Full Text] [Related]
14. Ginkgo biloba leaf extract (EGb 761) enhances catalepsy induced by haloperidol and L-nitroarginine in mice.
Fontana L; Souza AS; Del Bel EA; Oliveira RM
Braz J Med Biol Res; 2005 Nov; 38(11):1649-54. PubMed ID: 16258634
[TBL] [Abstract][Full Text] [Related]
15. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
[TBL] [Abstract][Full Text] [Related]
17. [Effect of haloperidol on changes in development of spontaneous catalepsy during subchronic injections of dopamine agonists and antagonists].
Kozlovskiĭ VL
Patol Fiziol Eksp Ter; 2012; (3):75-80. PubMed ID: 23072116
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic methamphetamine on SCH23390- or haloperidol-induced catalepsy, and effects of coadministration of SCH23390 or haloperidol in mice.
Mizuki Y; Ushijima I; Yamada M
Pharmacol Biochem Behav; 1996 Feb; 53(2):437-40. PubMed ID: 8808155
[TBL] [Abstract][Full Text] [Related]
19. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
Pearce RK; Banerji T; Jenner P; Marsden CD
Mov Disord; 1998 Mar; 13(2):234-41. PubMed ID: 9539335
[TBL] [Abstract][Full Text] [Related]
20. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Johnson AM; Loew DM; Vigouret JM
Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]